Global Dexlansoprazole Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dexlansoprazole Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).
Dexlansoprazole report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dexlansoprazole market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastroesophageal Reflux Disease and Heal Erosive Esophagitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dexlansoprazole industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dexlansoprazole key manufacturers include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical are top 3 players and held % sales share in total in 2022.
Dexlansoprazole can be divided into 30 mg and 60 mg, etc. 30 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Dexlansoprazole is widely used in various fields, such as Gastroesophageal Reflux Disease and Heal Erosive Esophagitis, etc. Gastroesophageal Reflux Disease provides greatest supports to the Dexlansoprazole industry development. In 2022, global % sales of Dexlansoprazole went into Gastroesophageal Reflux Disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dexlansoprazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
Segment by Type
30 mg
60 mg
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dexlansoprazole market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dexlansoprazole, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dexlansoprazole industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Dexlansoprazole in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dexlansoprazole introduction, etc. Dexlansoprazole Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dexlansoprazole market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Dexlansoprazole report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dexlansoprazole market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastroesophageal Reflux Disease and Heal Erosive Esophagitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dexlansoprazole industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dexlansoprazole key manufacturers include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical are top 3 players and held % sales share in total in 2022.
Dexlansoprazole can be divided into 30 mg and 60 mg, etc. 30 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Dexlansoprazole is widely used in various fields, such as Gastroesophageal Reflux Disease and Heal Erosive Esophagitis, etc. Gastroesophageal Reflux Disease provides greatest supports to the Dexlansoprazole industry development. In 2022, global % sales of Dexlansoprazole went into Gastroesophageal Reflux Disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dexlansoprazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
Segment by Type
30 mg
60 mg
Segment by Application
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dexlansoprazole market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dexlansoprazole, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dexlansoprazole industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Dexlansoprazole in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dexlansoprazole introduction, etc. Dexlansoprazole Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dexlansoprazole market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices